Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients by Tryggve Lundar et al.
ORIGINAL PAPER
Neurosurgical treatment of brain tumors in the first 6 months
of life: long-term follow-up of a single consecutive institutional
series of 30 patients
Tryggve Lundar1 & Bernt Johan Due-Tønnessen1 & Arild Egge1 & Bård Krossnes2 &
Einar Stensvold3 & Paulina Due-Tønnessen4 & Petter Brandal5
Received: 12 February 2015 /Accepted: 9 June 2015 /Published online: 15 July 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Object The aim of this study is to delineate the long-term
results for patients going through surgery for pediatric brain
tumors in the first 6 months of life.
Methods Thirty consecutive children (1–182 days old) who
underwent primary resection for a brain tumor during the
years 1973–2012 were included in this retrospective study
on surgical morbidity, mortality rate, academic achievement,
and/or work participation. Gross motor function and activities
of daily life were scored according to the Barthel index.
Results Of the 30 patients, 11 children had surgery in the first
3 months of life (1 to 88 days) and 19 were aged 3 to 6 months
(94–182 days) at the time of surgery. The male/female ratio
was 1.0 (15/15). No patients were lost to follow-up. Two pa-
tients died in the postoperative period (30 days). Another eight
patients died during the follow-up. Twenty patients are alive,
with follow-up times from 2 to 38 years, median 13 years.
Among the 28 children who survived the primary resection,
eight underwent repeat surgery from 6 months to 5 years after
the first operation. Two children were operated three times,
and one of these also a fourth time. Gross total resection
(GTR) was achieved in 20 of the primary resections, subtotal
resection (STR) in 6, and in the last 4, only a biopsy or a partial
resection was performed.
Nine children received adjuvant chemotherapy and three of
these also radiotherapy (in the years 1979–1987). Among the
20 survivors, the Barthel index is normal (100) in 18 patients,
40 in one, and 20 in the last one. Eight tumors were located to
the posterior fossa, and 22 were supratentorial. Eighteen tu-
mors were histologically low-grade (WHO grade I–II), most
of these were plexus papillomas (7) or astrocytomas (7),
and 12 were h igh -g rade (WHO grade I I I– IV) ;
PNET/medulloblastomas (6), ependymoma (2), glioblastoma
(2), teratoma, and plexus carcinoma.
Conclusion Infants with brain tumors may clearly benefit
from surgical resection with favorable results even for
prolonged periods of time. Ten children died, two of them
with prolonged survival for 9 and 29 years. Among the 20
survivors, a stable very long-term result appears obtainable
in 18 also when it comes to quality of life. Four of the survi-
vors have been treated for highly malignant tumors with a
follow-up of 5, 11, 14, and 26 years. One of our infant patients
treated for GBM in 1982, lived for 29 years, however, with a
progressive decline in the quality of life probably due to post-
operative whole-brain radiation.
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Introduction
Brain tumors diagnosed in the first 6 months of life are consid-
ered to have a very dismal prognosis [2, 3, 13-17, 20]. Surgical
brain tumor resection in very young children carries a
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higher morbidity andmortality risk compared to older children;
however, infants may tolerate brain tumor surgery remarkably
well. The postoperative survival of such small children with
highly malignant tumors was improved in the 1970s and
1980s, when postoperative radiotherapy was implemented [1,
22]. The clinical results over time were, however, worrisome
due to the progressive harmful effects of radiotherapy. In most
institutions, radiotherapy was therefore deferred in children be-
low the age of 3 years from the late 1980s. Clinical trials with
more precise local radiotherapy as well as chemotherapy in small
children have been performed for many years, but surgical resec-
tion remains amainstay of themultimodal therapy formost of the
youngest brain tumor patients [6–9, 21, 23].
Methods
Case identification and data collection
We retrospectively analyzed a consecutive cohort of 30 pa-
tients in their first 6 months of life (aged 183 days or younger)
who underwent resection for a brain tumor in the Department
of Neurosurgery, The National Hospital, Oslo, Norway, be-
tween 1973 and 2012. The cases were collected from surgical
protocols of the relevant time period, and all cases of intracra-
nial tumors operated in this period were included. Tumor lo-
calization was posterior fossa in 8 children (27 %) and
supratentorial in 22 children (73 %). Histology has been
reviewed by an experienced neuropathologist.
The case record data include sex, age at the time of primary
tumor resection, and information on repeat resection as well as
management of hydrocephalus.
Scholastic outcome was simplified into normal versus spe-
cial schooling, and employment attendance into open, shel-
tered, or no work.
This series comprises our operative experience of brain tu-
mors in infants during four decades.Most of the children (28 out
of 30) were operated after introduction of CT in 1977 and MRI
in our institution in 1987 (26 out of 30; Table 1). Two patients
underwent ventriculography before tumor resection. In the
others, the tumor was visualized on preoperative CT/MRI, and
repeat MRI scans were introduced in the follow-up program.
The aim of the surgical procedure was gross total resection
(GTR) or at least a substantial reduction of the tumor volume
(STR). The degree of resection was evaluated by the surgeon
and after 1987 by immediate postoperative MRI scans, most
often in the same anesthetical procedure as the surgery.
Assessment of functional status
The Barthel index score is a well-established and validated
scale using ten variables to measure performance in basic
activities of daily living (ADL) primarily related to personal
care and mobility [18]. Scores range from 0 to 100, and a
higher score denotes greater independence. The purpose was
to assess functional status and illustrate eventual differences
among subgroups within our cohort.
Results
The age of the children at primary surgery is given in Table 1.
Of the 30 patients, 11 children were in the first 3 months of life
(1 to 88 days) and 19 were aged 3 to 6 months (94–182 days).
The male/female ratio was 1.0 (15/15). No patients were lost
to follow-up, which ended by December 31, 2013. Two pa-
tients died in the postoperative period (within 30 days from
surgery). Another eight patients died during follow-up.
Surgery resulted in GTR in 20 patients, STR in 6, partial
resection in 2, and in the last two patients, only a biopsy was
taken. Twenty patients are alive, with follow-up times ranging
from 2 to38 years, median 13 years (Table 1).
The most common clinical presentation in these infants
was macrocephaly and symptoms of increased intracranial
pressure (tense fontanelle, vomiting), which was seen in 24
cases. These symptoms were particularly pronounced in two
infants with acute hemorrhage in the tumor (patients 4 and
15). Five children had one or more seizures preoperatively,
and three infants presented with cranial nerve dysfunction.
The histological examination revealed low-grade (WHO
grade 1 or 2) tumors in 18 patients (Table 1): seven astrocy-
tomas, seven plexus papillomas, two gangliogliomas, and two
hamartomas. Three of the four optical pathway astrocytomas
were of the pilomyxoid type (patients 17, 25, and 27 in
Table 1). Three of the plexuspapillomas were WHO grade 2
(patients 13, 14, and 24). The two gangliogliomas were of the
desmoplastic infantile type (patients 20 and 29).
Twelve tumors were high-grade (WHO grade 3 or 4): six
PNET/medulloblastomas, two ependymomas, two glioblasto-
mas (GBM), one teratoma, and one plexus carcinoma.
Two patients died early. One of the postoperative deaths
occurred in 1973 when a 5-month-old girl died after a resec-
tion of what turned out to be a GBM. The other patient that
died postoperatively was a 2-month-old boy with a very large
optical pathway astrocytoma. Only a small biopsy was taken.
Because of the tumor size the situation was considered palli-
ative and no antineoplastic treatment was indicated. The pa-
tient died 2 days postoperatively after the parents had been
informed about the situation and consented to stop treatment.
Adjuvant and further treatment
Repeat resections were performed in eight patients due to tumor
progression. Six of eight repeat resections were performed in
children with low-grade tumors. Three infants with high-grade
tumors (patients 3, 4, and 5) received whole-brain postoperative
2284 Childs Nerv Syst (2015) 31:2283–2290
radiotherapy (45 Gy) in the years 1979–1987; they stayed alive
for 4, 29, and 1.5 years, respectively.
Nine patients received chemotherapy, six of the patients
with high-grade tumors and three children with low-grade
tumors (Table 1). Five patients had CSF shunt procedures
due to persistent hydrocephalus.
Motorical function and activities of daily life
Among the 20 survivors, the Barthel index score is 100 in 18
patients. Patient 27 is alive with disease with a score of 20, but
in a terminal condition, after almost continuous treatment for
an aggressive optic-pathway glioma including chemotherapy,
four tumor resections and several shunt procedures. The last
patient (patient 10) presented with tetraplegia and respiratory
arrest 34 days old and MRI disclosed a lipoma innside medul-
la oblongata with exophytic extension to the fourth ventricle
as well as behind the cervical medulla. After partial resection,
the patient regained spontaneous respiration, swallowing
function, and some motorical function in the upper extremi-
ties. She underwent repeat resections after 8 and 10 years due
to tumor growth and clinical deterioration. At present, she has
a Barthell index score of 40, is driving her own car, but is
dependent on an electrical wheel chair to move around.
School, education, and work
Four of the survivors are still below school age (2–5 years),
whereas 10 patients are aged 8–16 years and they all follow
regular school programs.
Table 1 Patient demographics
Patient Year Age days Localization Histology Primary
resection




1 1973 F 161 L hemisphere GBM STR No P.o. death Dead
2 1975 F 129 Cerebellum Astrocytoma GTR No 38 years 100
3 1979 M 171 Cerebellum Medulloblastoma GTR RT 4 years Dead
4 1982 F 152 R hemisphere GBM GTR RT 29 years Dead
5 1987 F 165 R frontal PNET GTR RT, ChT 1.5 years Dead
6 1987 F 94 Brain stem Teratoma STR No 0.5 years Dead
7 1987 M 178 Lateral ventr Plex papillom GTR No 27 years 100
8 1988 M 66 Lateral ventr Plex carcin GTR RS, HC 26 years 100
9 1990 F 124 IV ventricle Medulloblastoma GTR No 0.6 years Dead
10 1990 F 34 Brain stem Lipoma Partial res RSx2 24 years 40
11 1990 M 3 cerebellum Astrocytoma GTR No 23.5 years 100
12 1991 M 18 III ventricle Plex papilloma GTR No 23 years 100
13 1998 M 147 Lateral ventr Plex papilloma GTR No 16 years 100
14 2000 F 46 Lateral ventr Plex papilloma GTR No 14 years 100
15 2000 F 127 L frontal PNET GTR ChT 14 years 100
16 2000 M 147 III ventricle Plex papilloma GTR No 14 years 100
17 2000 F 173 Opt pathway Astrocytoma STR RS 9 years Dead
18 2002 M 161 Brain stem Ependymoma GTR RS, HC 2 years Dead
19 2003 M 58 Cerebellum Epend. blastoma GTR ChT, HC 11 years 100
20 2004 M 88 R temporal Ganglioglioma GTR No 10 years 100
21 2004 F 71 Lateral ventr Plex papilloma GTR No 10 years 100
22 2004 M 182 Cerebellum Medulloblastoma STR ChT, RS 1.6 years Dead
23 2005 F 122 Opt pathway Astrocytoma STR ChT, RS 9.5 years 100
24 2006 F 107 III ventricle Plex papilloma GTR No 8.5 years 100
25 2006 M 56 Opt pathway Astrocytoma Biopsy No P.o. death Dead
26 2006 M 1 R hemisphere SEGA Biopsy ChT, HC, RSx2 8 years 100
27 2009 F 164 Opt pathway Astrocytoma Partial res ChT, HC, RSx3 4.5 years 20
28 2009 F 165 R hemisphere Anaplastic ependymoma GTR ChT, RSx2 5 years 100
29 2010 M 142 R hemisphere Ganglioglioma GTR No 4.5 years 100
30 2012 M 48 Hypothalamus Hamartoma STR No 2 years 100
GTR gross total resection, STR subtotal resection, RT radiotherapy, ChT chemotherapy, RS repeat tumor surgery, HC surgery for hydrocephalus, SEGA
subependymal giant cell astrocytoma, GBM glioblastoma, PNET primitive neuroectodermal tumor
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Six patients are aged 23–38 years of which three are stu-
dents or in regular work, one is in full-time sheltered work,
and the last two are outside the labor market. One of these
(patient 10, see above) is wheel-chair dependent with normal
cognition, whereas the other (patient 8) is suffering from se-
vere epilepsy.
Long-term outcome—surgical resection
There are 20 survivors with follow-up from 2 to 38 years,
median 13 years (Table 1). Survival was related to the surgical
resection (Fig. 3). Fifteen of the 20 infants who had a GTR at
primary surgery are alive with follow-up from 4.5 to 38 years.
Five are dead, after 0.6, 1.5, 2, 4, and 29 years. The latter was a
5-month-old girl (patient 4) who underwent GTR for a glio-
blastoma followed by whole brain radiotherapy (45 Gy) in
1982. Initially, she recovered quite well, but from the age of
12 months she deteriorated over years with severe epilepsy
and loss of clinical skills including cognitive functions.
There was a continuous negative development until she died
29 years old in status epilepticus. A CT scan showed several
radiation induced meningeomas but no evidence of glioblas-
toma regrowth.
In the ten patients with non-GTR, i.e., STR, partial resec-
tion, or biopsy; two patients died in the postoperative period as
described above. Among the eight infants that survived the
early postoperative period, another 3 are dead after 0.5, 1.6,
and 9 years. Five are alive with follow-up periods of 2, 4.5, 8,
9.5, and 24 years.
Long-term outcome—tumor histology
Low-grade
Outcome in terms of survival was clearly related to histology.
Sixteen of the 18 infants with low-grade tumors are alive after
follow-up periods ranging from2 to 38 years,median 12 years.
Figure 1 shows preoperative and postoperativeMRI scans of a
5-month-old boy with a third ventricular plexus papilloma
(patient 16). His clinical outcome has been uneventful for
the next 14 years. The two deceased patients both had aggres-
sive optical pathway tumors. One died early postoperatively
and the other after 9 years and two surgical resections.
Figure 4 combines the effect of low-grade histology and
GTR versus non-GTR on survival.
High-grade
Twelve patients had high-grade tumors. Four are alive with
follow-up periods of 5, 11, 14, and 26 years. One child died in
the early postoperative phase; six children died from progres-
sive disease after 0.5, 0.6, 1.5, 1.6, 2, and 4 years in spite of
multimodal therapy; and one patient died after 29 years—
supposedly from late effects of radiotherapy (see above).
Figure 2 shows preoperative and postoperative MRI scans
for patient 15. She underwent GTR for a supratentorial
PNET followed by chemotherapy according toHIT-2000.
Fourteen years later, she follows a normal school program
with some assistance, without evidence of recurrent disease.
Two of the children with malignant tumors underwent re-
peat tumor resection and three had adjuvant chemotherapy
after the first tumor resective surgery (Table 1). The clinical
condition is stable and the last follow-up MRI did not dem-
onstrate active disease. Figure 4 illustrates that all survivors
with malignant disease had a GTR, whereas none of the in-
fants with high-grade neoplasms survived following non-
GTR surgery.
Discussion
Children treated for brain tumors during the first 6 months
of life have been considered to have a dismal prognosis,
although clinical reports on results for this specific age
group are few [16, 24]. Numerous institutional series de-
scribing outcome for children following brain tumor surgery
in the first year of life have been published [2, 4, 12, 17, 22,
25]. In all these series, the majority of tumors in infants have
been supratentorial, a finding corroborated by us. The clin-
ical outcome is described as very challenging for the age
group below 6 months of age, both in terms of impaired
survival rates and major neurological deficits in many of
the survivors [16, 24]. It is well known that age may influ-
ence the result. Improved survival figures for children with
high-grade brain tumors was the result following the intro-
duction of postoperative radiation therapy, especially in chil-
dren with medulloblastoma. However, while survival was
increased, a reduction in the quality of life was observed
over time, more evident in youngest children under the age
of 3 years. Our present series also include an example of this
pertinent problem—progressive clinical deterioration over
29 years after an uneventful clinical outcome during the first
6 months. The disastrous clinical result, exemplified by this
case history, was one of the reasons why we like many
others stopped postoperative radiotherapy for high-grade
brain tumors in children below the age of 3 years from the
late 1980s.
The knowledge about harmful side effects following cen-
tral nervous system radiotherapy in young age led to several
clinical trials of chemotherapy in the management of brain
tumors in small children, with the purpose of avoiding or
deferring radiation therapy. A number of reports have fo-
cused on survival and outcome data for small children treat-
ed for high-grade brain tumors with postponed radiation
therapy.
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Many of these studies underscore the importance of GTR
as an individual prognostic factor for survival. Our present
series support this opinion, although the absolute numbers
are limited. Of the 20 survivors, 14 had undergone a GTR.
Additionally, there was a long-term survivor who died after
29 years without signs of progressive tumor disease after
GTR for a GBM, although postoperative radiotherapy most
probably contributed to this result. All the 11 patients with
low-grade tumors who had a GTR are alive, whereas 5 out
of 7 with non-GTR are alive, some after repeat resections.
Four infants treated for high-grade tumors are alive; all had a
GTR. Five others with GTR are dead, all within 4 years
from surgery—with the exception of the girl that died after
29 years from treatment side effects, and not from tumor
progression. The three children without GTR all died within
1.5 years.
Although GTR seems very important, it should be noted
that the favorable survival data from this series may be in-
fluenced by several other factors as well. The high incidence
of plexus tumors in the first year of life is well known [1, 4,
11, 13, 14, 24, 25], and the case-mix with eight plexus
tumors in our series, seven of them papillomas, are tumors
with a good prognosis. These patients are all survivors in-
cluding the infant treated for a carcinoma with surgery
alone. The latest follow-up MRIs are without residual tumor.
There were also two cases of cerebellar astrocytoma, rather
Fig. 1 Patient 16. Five-month-old boy presenting with rapidly increasing head circumference and tense fontanelle. Preoperative and postoperative axial
and sagittal MRI scans after GTR for the third ventricle plexus papilloma. The patient has 14-year event-free survival
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uncommon at this early age and also tumors with generally
good long-term results [5]. On the other hand, there were
also four low-grade optical pathway astrocytomas, of which
two died in spite of aggressive treatment. The disproportion-
ately high incidence of such aggressive tumors in this age
group (also called chiasmatic-hypothalamic gliomas) is also
well known [22]. Although histologically low-grade, they
may be difficult to treat.
The poor prognosis for infants with brain tumors is also
related to congenital tumors, and often very large tumors, and
aggressive high-grade tumors responding poorly to antineo-
plastic therapy. In this series, there was no single case of AT/
RT among the neonates with PNETs, but one case of
ependymoblastoma with an unexpected good long-term sur-
vival. Our results suggest that GTR may influence the out-
come for these patient groups, but the consequences of radical
excision may be additional neurological sequelae. On the oth-
er hand, even small children tolerate surgery remarkably well
and often recover from severe immediate postoperative neu-
rological deficits with time. Of 28 infants that survived the
early postoperative period, seven had repeat surgery and, four
of these more than once.
Chemotherapy is a good alternative management strategy
for infants with high-grade and also some with low-grade
tumors. However, considered the good tolerance also for
surgery, further resection should be discussed until further
tumor surgery is no longer possible or is inappropriate.
Radiotherapy should be deferred as long as possible and high
precision techniques should always be used.
The clinical implications of a brain tumor in infancy may
be severe for the child and their family. Survival data may
illustrate the impact upon prognosis of multimodal treatment
with surgery, chemotherapy, and radiotherapy [10, 19].
However, the quality of life for survivors is also very impor-
tant. Eighteen of 20 survivors in the present series have a good
long-term prognosis in terms of prolonged survival. They also
have a normal Barthel index score, indicating that they per-
form activities of daily life unassisted.
Detailed clinical long-term results in previous infant
brain tumor cohorts are not available. Apart from three
children treated between 1979 and 1987, our infants
have not received radiotherapy. The clinical problems
they face today are therefore caused by the neoplastic
disease, surgical resections and handling of their hydro-
cephalus (five patients), and chemotherapy. This holds
promise for a stable and long-lasting good clinical out-
come for these patients, without deterioration over time,
like we had to face in the patient who survived whole-
brain radiation at this age after GTR for a GBM in
1982.
Fig. 2 Patient 15. Four-month-old girl with acute symptoms (seizures) due to a hemispheric PNETwith acute bleeding. She underwent GTR followed
by chemotherapy. She has a 14-year event-free survival. Coronal and axial preoperative and postoperative MRI scans are shown
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For infants with brain tumors, a long-term follow-up
and in principle life-long follow-up is needed to fully
understand the impact of neoplastic disease and its man-
agement on quality of life including early school years,
higher education, and social integration. As the median
follow-up time for our survivors is only 12–13 years,
we only know that most of them do fairly well in
school. Out of six survivors with 23–38-year follow-
up, four are living normal lives as students or in full-
time work, whereas two are outside the labor market
and with severe medical problems (one with severe ep-
ilepsy and, the other wheel-chair dependent but car
driver with good cognition).
Some previous series report major disability in most
survivors even after resections for low-grade tumors in
infants [12, 16, 24, 25]. Our experience is more differ-
entiated with a large number of rewardable outcomes.
This may be influenced by the high proportion of plex-
us tumors and a total proportion of low-grade lesions of
60 %. Our results are more like early reports with a
majority of benign lesions leading to good outcome
for many of the survivors [1, 4, 22].
In our series, no patient has been lost to follow-up
(Figs. 3 and 4). Because many of these patients live for
many years, radiation of the brain should not be under-
taken in low-grade patients, until further resection seems
inappropriate. Although the numbers are small for in-
fants with high-grade tumors, GTR followed by chemo-
therapy appears to give a chance for a relatively good
result. The group dying from their malignant disease did
so within a few years, at an age where radiotherapy
might induce severe harmful effects if they should end
up as long-term survivors.
Conclusion
Brain tumors occurring in the first 6 months of life can be
treated with rewarding long-term results in many cases.
GTR was achievable in 67 % of infants and led to good
tumor control in all children with low-grade lesions and in
4 out of 8 infants with high-grade tumors when followed
by chemotherapy.
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